{
    "clinical_study": {
        "@rank": "38365", 
        "arm_group": {
            "arm_group_label": "Gas mixture administration", 
            "arm_group_type": "Experimental", 
            "description": "Subjects will breathe different gas mixtures with different densities and viscosity for brief periods in order to promote changes in peak inspiratory flow"
        }, 
        "brief_summary": {
            "textblock": "In obstructive sleep apnea (OSA), the upper airway recurrently closes during sleep. The\n      mechanisms that lead to airway closure are not completely understood. Models to study\n      mechanisms of airway collapse have been proposed. However, these models have not been tested\n      in the human upper airway. Gas density and viscosity are different gas properties that\n      influence upper airway collapse and are variables of different models. In this study,\n      subjects will breathe gas mixtures of different densities and viscosities for brief periods\n      of time in order to test those models."
        }, 
        "brief_title": "Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "Models to study mechanisms of airway collapse have been proposed. However, these models have\n      not been tested in the human upper airway. Gas density and viscosity are different gas\n      properties that influence upper airway collapse and are variables of different models.\n\n      In this study, subjects will breathe gas mixtures of different densities (helium and\n      sulfur-hexafluoride) or viscosity (neon) for brief periods of time during flow-limited\n      breaths. Flow limitation will be induced by sustained reductions of continuous positive\n      airway pressure (CPAP). The investigators will test some models of upper airway collapse by\n      observing if flow while breathing different gas mixtures scales according to the differences\n      in density and viscosity."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Normal subjects or patients with OSA\n\n        Exclusion Criteria:\n\n          -  Any unstable cardiac condition (other than well controlled hypertension) or pulmonary\n             problems.\n\n          -  Any medication known to influence breathing, sleep/arousal or muscle physiology\n\n          -  Concurrent sleep disorders (insomnia, narcolepsy, central sleep apnea or parasomnia)\n\n          -  Claustrophobia\n\n          -  Inability to sleep supine\n\n          -  Allergy to lidocaine or oxymetazoline hydrochloride\n\n          -  For women: Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01738022", 
            "org_study_id": "2012P000957C", 
            "secondary_id": "1R01HL102321-01A1"
        }, 
        "intervention": {
            "arm_group_label": "Gas mixture administration", 
            "intervention_name": "Administration of gas mixtures", 
            "intervention_type": "Other", 
            "other_name": [
                "Heliox", 
                "Sulfur-hexafluoride", 
                "Neon"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sleep apnea", 
            "Pathophysiology"
        ], 
        "lastchanged_date": "September 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Brigham and Women's Hospital"
            }, 
            "investigator": {
                "last_name": "Pedro R Genta, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C", 
        "overall_contact": {
            "email": "pgenta@partners.org", 
            "last_name": "Pedro R Genta, MD", 
            "phone": "(617) 732-6541"
        }, 
        "overall_contact_backup": {
            "email": "lhess1@partners.org", 
            "last_name": "Lauren B Hess, BS", 
            "phone": "(617) 732-8976"
        }, 
        "overall_official": {
            "affiliation": "Brigham and Women's Hospital", 
            "last_name": "David A Wellman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Observed peak inspiratory flow while breathing different gas mixtures will be compared to model predicted flows.\nSubjects will breathe different gas mixtures for 2 consecutive breaths only. Therefore the time frame is equal to one breath before gas mixture administration and two breaths after (usually 10-15 seconds).", 
            "measure": "Difference in peak inspiratory flow", 
            "safety_issue": "No", 
            "time_frame": "10 - 15 seconds"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01738022"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "David Andrew Wellman", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}